Cargando…
Epigenetic and miRNAs Dysregulation in Prostate Cancer: The role of Nutraceuticals
The control of cancer onset and progression is recognized to benefit from specific molecular targeting. MiRNAs are increasingly being implicated in prostate cancer, and the evidence suggests they are possible targets for molecular therapy and diagnosis. In cancer cells, growing attention has been de...
Autores principales: | Bosutti, Alessandra, Zanconati, Fabrizio, Grassi, Gabriele, Dapas, Barbara, Passamonti, Sabina, Scaggiante, Bruna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5068501/ https://www.ncbi.nlm.nih.gov/pubmed/27109021 http://dx.doi.org/10.2174/1871520616666160425105257 |
Ejemplares similares
-
High eEF1A1 Protein Levels Mark Aggressive Prostate Cancers and the In Vitro Targeting of eEF1A1 Reveals the eEF1A1–actin Complex as a New Potential Target for Therapy
por: Bosutti, Alessandra, et al.
Publicado: (2022) -
An Overview of Circulating Cell-Free Nucleic Acids in Diagnosis and Prognosis of Triple-Negative Breast Cancer
por: Tierno, Domenico, et al.
Publicado: (2023) -
Dissecting the expression of EEF1A1/2 genes in human prostate cancer cells: the potential of EEF1A2 as a hallmark for prostate transformation and progression
por: Scaggiante, B, et al.
Publicado: (2012) -
Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches
por: Jesenko, Tanja, et al.
Publicado: (2023) -
Xenograft Zebrafish Models for the Development of Novel Anti-Hepatocellular Carcinoma Molecules
por: Tonon, Federica, et al.
Publicado: (2021)